Friday, March 30, 2012
Seizure Control for Patients Undergoing Meningioma Surgery
Source:World Neurosurgery
Kaisorn L. Chaichana, Courtney Pendleton, Hasan Zaidi, Alessandro Olivi, Jon D. Weingart, Gary L. Gallia, Michael Lim, Henry Brem, Alfredo Quinones-Hinojosa
Objective Seizures are common among patients with meningiomas and are a significant cause of morbidity and poor quality of life. The factors associated with the onset of seizures as well as factors associated with seizure control remains poorly understood. Methods Adult patients who underwent primary resection of a supratentorial World Health Organization grade I meningioma at a single institution between 1996 and 2006 were retrospectively reviewed. Multivariate logistical regression analysis was used to identify associations with pre-operative seizures, and multivariate proportional hazards regression analyses were used to identify associations with prolonged seizure control following surgical resection. Results Of the 626 patients in this series, 84 (13%) presented with seizures. The factors independently associated with pre-operative seizures were: Karnofsky performance score (KPS) ≤ 80 (p<0.0001), absence of headaches (p=0.0006), and vasogenic edema (p=0.007). At 48-months post-operatively, 90% were Engel Class I, 3% were Class II, 0% were Class III, and 7% were Class IV. The factors independently associated with decreased seizure control following surgical resection were: uncontrolled pre-operative seizures (p=0.04), parasagittal tumors (p=0.03), and tumors along the sphenoid wing (p=0.05). The association between seizure recurrence and tumor recurrence trended towards but did not achieve statistical significance (p=0.11). Conclusion With the widespread availability of various neuro-imaging modalities, there will be increased detection of intracranial meningiomas. The identification and consideration of factors associated with seizure onset and prolonged seizure control may help guide treatment strategies aimed at improving the quality of life for patients with meningiomas.
Monday, March 26, 2012
Surgical management of ventral and ventrolateral foramen magnum meningiomas: report on a 64-case ser
- Content Type Journal Article
- Category Original Article
- Pages 1-10
- DOI 10.1007/s10143-012-0381-6
- Authors
- Andrea Talacchi, Section of Neurosurgery, Department of Neuroscience, University of Verona, Verona, Italy
- Antonio Biroli, Institute of Neurosurgery, University Hospital, Verona, Italy
- Christian Soda, Institute of Neurosurgery, University Hospital, Verona, Italy
- Barbara Masotto, Institute of Neurosurgery, University Hospital, Verona, Italy
- Albino Bricolo, Section of Neurosurgery, Department of Neuroscience, University of Verona, Verona, Italy
- Journal Neurosurgical Review
- Online ISSN 1437-2320
- Print ISSN 0344-5607
Mutations Detected Within A Brain Tumor Using Non-Invasive Imaging
Sunday, March 25, 2012
Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma
Subependymal giant cell astrocytomas (SEGAs) are benign tumors, most commonly associated with tuberous sclerosis complex (TSC). Arising from the lateral ependymal surface, these tumors may obstruct one or both foramina of Monro, resulting in hydrocephalus and often requiring treatment. Although interhemispheric-transcallosal and transcortical-transventricular approaches have been the standard methods for resecting these tumors, advances in neuroendoscopic techniques have expanded SEGAs as a potential target for endoscopic resection. The authors present a case of an endoscopically resected SEGA with stereotactic guidance in a 4-year-old girl with TSC. A gross-total resection of an enlarging SEGA was achieved. This represents one of the early case reports of endoscopically resected SEGAs. Although recent advances in medical treatment for SEGAs with mammalian target of rapamycin (mTOR) pathway inhibitors have shown promising initial results, the long-term safety and efficacy of mTOR inhibitors has yet to be determined. The propensity of these tumors to cause obstructive hydrocephalus requires that a surgical option remain. Neuroendoscopic approaches may allow a safe and effective technique.
Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgery
Object Postoperative CSF leakage can be a serious complication after a transsphenoidal surgical approach. An elevated body mass index (BMI) is a significant risk factor for spontaneous CSF leaks. However, there is no evidence correlating BMI with postoperative CSF leak after transsphenoidal surgery. The authors hypothesized that patients with elevated BMI would have a higher incidence of CSF leakage complications following transsphenoidal surgery. Methods The authors conducted a retrospective review of 121 patients who, between August 2005 and March 2010, underwent endoscopic endonasal transsphenoidal surgeries for resection of primarily sellar masses. Patients requiring extended transsphenoidal approaches were excluded. A multivariate statistical analysis was performed to investigate the association of BMI and other risk factors with postoperative CSF leakage. Results In 92 patients, 96 endonasal endoscopic transsphenoidal surgeries were performed that met inclusion criteria. Thirteen postoperative leaks occurred and required subsequent treatment, including lumbar drainage and/or reoperation. The average BMI of patients with a postoperative CSF leak was significantly greater than that in patients with no postoperative CSF leak (39.2 vs 32.9 kg/m2, p = 0.006). Multivariate analyses indicate that for every 5-kg/m2 increase in BMI, patients undergoing a transsphenoidal approach for a primarily sellar mass have 1.61 times the odds (95% CI 1.10–2.29, p = 0.016, by multivariate logistic regression) of having a postoperative CSF leak. Conclusions Elevated BMI is an independent predictor of postoperative CSF leak after an endonasal endoscopic transsphenoidal approach. The authors recommend that patients with BMI greater than 30 kg/m2 have meticulous sellar reconstruction at surgery and close monitoring postoperatively.
Morbidity profile following aggressive resection of parietal lobe gliomas
Object The impact of parietal lobe gliomas is typically studied in the context of parietal lobe syndromes. However, critical language pathways traverse the parietal lobe and are susceptible during tumor resection. The authors of this study reviewed their experience with parietal gliomas to characterize the impact of resection and the morbidity associated with language. Methods The study population included adults who had undergone resection of parietal gliomas of all grades. Tumor location was identified according to a proposed classification system for parietal region gliomas. Low- and high-grade tumors were volumetrically analyzed using FLAIR and T1-weighted contrast-enhanced MR imaging. Results One hundred nineteen patients with parietal gliomas were identified—34 with low-grade gliomas and 85 with high-grade gliomas. The median patient age was 45 years, and most patients (53) presented with seizures, whereas only 4 patients had an appreciable parietal lobe syndrome. The median preoperative tumor volume was 31.3 cm3, the median extent of resection was 96%, and the median postoperative tumor volume was 0.9 cm3. Surprisingly, the most common early postoperative neurological deficit was dysphasia (16 patients), not weakness (12 patients), sensory deficits (14 patients), or parietal lobe syndrome (10 patients). A proposed parietal glioma classification system, based on surgical anatomy, was predictive of language deficits. Conclusions This is the largest reported experience with parietal lobe gliomas. The findings suggested that parietal language pathways are compromised at a surprisingly high rate. The proposed parietal glioma classification system is predictive of postoperative morbidity associated with language and can assist with preoperative planning. Taken together, these data emphasize the value of identifying language pathways when operating within the parietal lobe.
The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): Development and validation of an in
Source:European Journal of Cancer, Volume 48, Issue 6
Patricia Minaya, Karine Baumstarck, Julie Berbis, Anthony Goncalves, Fabrice Barlesi, Gérard Michel, Sébastien Salas, Olivier Chinot, Jean-Jacques Grob, Jean François Seitz, Franck Bladou, Audrey Clement, Julien Mancini, Marie-Claude Simeoni, Pascal Auquier
Purpose The study objective was to validate a specific quality of life (QoL) questionnaire for caregivers of cancer patients, the CareGiver Oncology Quality of Life questionnaire (CarGOQoL), based on the exclusive points of view of the caregivers. Materials and methods A 75-item questionnaire generated from content analysis of interviews with caregivers was self-completed by 837 caregivers of cancer patients. In addition to sociodemographic data and patient characteristics, self-reported questionnaires assessing QoL, burden, coping and social support were collected. Psychometric properties combined methods relying on both classical test theory and item response theory. Results The final 29 items selected assessed 10 dimensions: psychological well-being, burden, relationship with health care, administration and finances, coping, physical well-being, self-esteem, leisure time, social support and private life; they were isolated from principal component analysis explaining 73% of the total variance. The missing data and the floor effects were low. Some ceiling effects were found for B (34%). Cronbach's alpha coefficients ranged from 0.72 to 0.89, except private life (PL) (0.55). Unidimensionality of the scales was confirmed by Rasch analyses. Correlations with other instruments confirmed the isolated content and significant links were found with respect to patient's characteristics. Reproducibility and sensitivity to change were found satisfactory. Conclusion The CarGOQoL could provide a reliable and valid measure of caregivers of cancer patients' QoL which are key-actors in the provision of health care.
Thursday, March 22, 2012
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, a
Glioblastomas (GBMs) containing foci that resemble oligodendroglioma are defined as GBM with oligodendroglioma component (GBMO). However, whether GBMO is a distinct clinicopathological variant of GBM or merely represents a divergent pattern of differentiation remains controversial. We investigated 219 consecutive primary GBMs, of which 40 (18.3%) were confirmed as GBMOs. The clinical features and genetic profiles of the GBMOs were analyzed and compared with the conventional GBMs. The GBMO group showed more frequent tumor-related seizures (P= .027), higher frequency of IDH1 mutation (31% vs. <5%, P= .015), lower MGMT expression (P= .016), and longer survival (19.0 vs. 13.2 months; P= .022). In multivariate Cox regression analyses, presence of an oligodendroglioma component was predictive of longer survival (P= .001), but the extent of the oligodendroglial component appeared not to be linked to prognosis (P= .664). The codeletions of 1p/19q, somewhat surprisingly, were infrequent (<5%) in both GBMO and conventional GBM. In addition, the response to aggressive therapy differed: the GBMO group had no survival advantage associated with aggressive treatment protocols, whereas a clear treatment effect was observed in the conventional GBM group. Collectively, the clinical behavior and genetic alterations of GBMO thus differs from those of conventional GBM. Presence of an oligodendroglial component may therefore be a useful classification and stratification variable in therapeutic trials of GBMs.
Wednesday, March 21, 2012
Enhancing life after cancer in diverse communities
Abstract
BACKGROUND:
Although large numbers of cancer survivors exist in every community, including minority communities, there is a significant gap in knowledge about best practices for these patients.
METHODS:
The Community Networks Program, funded by the National Cancer Institute Center to Reduce Cancer Health Disparities, has developed and tested unique services for these communities. These programs have used community-based participatory research techniques under a framework of diffusion of innovation and communications theory.
RESULTS:
This article describes some specifically tailored interventions that may be useful to a wide range of providers working with the underserved.
CONCLUSIONS:
Enhancing life after cancer can be achieved in underserved communities by supplementing local resources. Cancer 2012;. © 2012 American Cancer Society.